Reneo Pharmaceuticals, Inc. (NasdaqGM:RPHM) announces a share repurchase program. Under the program, the company will repurchase up to 576,443 shares, for $4.4 million. The shares will be repurchased from vTv Therapeutics LLC (the ?Selling Stockholder?) at a price of $7.64 per share.